Is ‘Waste-To-Value’ The Next Big Private Equity Category?
That “waste-to-value” is increasingly getting quiet attention from private equity and infrastructure investors.
What private equity can teach executives about metrics: Fridson
Wall Street is often blamed for reducing corporate managers’ understanding of business to a single, gameable measure of ...
Once high-flying Bluebird Bio sells itself to private equity after tough times for the gene therapy maker
Bluebird Bio will sell itself to private equity firms Carlyle and SK Capital for about $30 million, the company said Friday.
Wall Street Is Selling ETFs That Mimic the Private Equity Boom
Wall Street is still awaiting regulatory approval for the first full-blown private-asset ETFs, but for now opportunistic ...
Private Equity Sees Deal Pipelines Filling In as Year Begins
Private-equity executives entered 2025 with high hopes for a dealmaking recovery that is lifting payouts to fund investors ...
Don't let them sue: What private equity bosses want from Trump on 401(k)s
Trump opened the door for private equity to tap 401(k)s, and now private equity bosses want legal protection. Here's what ...
Private Equity Gets Pushback on Attempts to Strip Investor Protections
In 2025’s go-go leveraged debt markets, everything is up for negotiation, but a trio of investor protections are proving to ...
The New Survival Guide for Private Equity: Go Big or Get Back to Basics
Successful firms are increasingly split between behemoths with several business lines and those focusing on their roots of ...
Private Equity, Venture Capital Flows To Biotechnology Lowest Since 2019
In 2024, global private equity and venture capital transaction value and volume in biotechnology declined to their lowest ...
What Do Tariffs Mean For Private Equity?
As US navigates a shifting landscape of trade policy under new administration, markets grappling with implications of ...
Navigating Private Equity Secondaries In An Era Of Changing Interest Rates
As stakeholders recalibrate their approaches, secondaries offer a proving ground for innovative capital strategies that could influence private equity far into the future.
Walgreens Stock Gains on Hopes Private-Equity Bid Is ‘Alive’
Last month, a deal for Sycamore Partners to buy pharmacy chain Walgreens was seen as “mostly dead,” but reports say it may ...